Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia - Top-Institutions - MDSpire

Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia

  • By

  • Yuto Sunaga

  • Yohei Hasebe

  • Masashi Yoshizawa

  • Yosuke Kono

  • Keiichi Koizumi

  • Nobuyuki Katsumata

  • Takako Toda

  • Minako Hoshiai

  • Koji Kobayashi

  • Sho Hokibara

  • Hiroko Oshiro

  • Emi Sawanobori

  • Tomoaki Sano

  • Masanori Ohta

  • Makoto Tsuruta

  • Makoto Nakamura

  • Kazumasa Sato

  • Hiroki Sato

  • Takeshi Inukai

  • June 4, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    University of Yamanashi Hospital
    University of Yamanashi Hospital

    Yamanashi, Japan

    Key Differentiators

    • Pediatrics

  • #2

    Children’s Hospital of Chongqing Medical University
    Children’s Hospital of Chongqing Medical University

    Chongqing, China

    Key Differentiators

    • Pediatrics

  • #3

    Taiwan Medical Center
    Taiwan Medical Center

    Taipei, Taiwan

    Key Differentiators

    • Pediatrics

Original Source(s)

Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia

  • by Yuto Sunaga, Yohei Hasebe, Masashi Yoshizawa, Yosuke Kono, Keiichi Koizumi, Nobuyuki Katsumata, Takako Toda, Minako Hoshiai, Koji Kobayashi, Sho Hokibara, Hiroko Oshiro, Emi Sawanobori, Tomoaki Sano, Masanori Ohta, Makoto Tsuruta, Makoto Nakamura, Kazumasa Sato, Hiroki Sato, Takeshi Inukai

  • June 4, 2026

Related Content

Combined Analysis by Peak and Submaximal Exercise Parameters Delineates Underlying Mechanisms of Poor Exercise Performance in Fontan Patients

Retrospective surgical outcomes of Gartland type III supracondylar humeral fractures with absent pulse in children

Case Report: ETV6 c.744del gene mutation acute lymphoblastic leukemia in identical twins